Events and Presentations Events and Presentations Past Events 2020 Annual Meeting of Stockholders Jun 11, 2020 Click Here for Webcast Presentations Corporate Presentation - August 2020 NextCure Presents Biomarker Data and Updated Clinical Results from Phase 1 Portion of its NC318 Clinical Trial at the 2020 Virtual American Society of Clinical Oncology Annual Meeting NextCure Hosts and Webcast Event at the 34th Annual Meeting of SITC NextCure Presents Clinical Data from NC318 Phase 1/2 Clinical Trial at the 34th Annual Meeting of SITC NextCure Presents Preclinical Data on NC318, a Novel Immunomedicine Targeting Siglec-15, at the Society for Immunotherapy of Cancer’s (SITC) 33rd Annual Meeting (PDF) Tools
Events and Presentations Past Events 2020 Annual Meeting of Stockholders Jun 11, 2020 Click Here for Webcast Presentations Corporate Presentation - August 2020 NextCure Presents Biomarker Data and Updated Clinical Results from Phase 1 Portion of its NC318 Clinical Trial at the 2020 Virtual American Society of Clinical Oncology Annual Meeting NextCure Hosts and Webcast Event at the 34th Annual Meeting of SITC NextCure Presents Clinical Data from NC318 Phase 1/2 Clinical Trial at the 34th Annual Meeting of SITC NextCure Presents Preclinical Data on NC318, a Novel Immunomedicine Targeting Siglec-15, at the Society for Immunotherapy of Cancer’s (SITC) 33rd Annual Meeting (PDF)
NextCure Presents Biomarker Data and Updated Clinical Results from Phase 1 Portion of its NC318 Clinical Trial at the 2020 Virtual American Society of Clinical Oncology Annual Meeting
NextCure Presents Clinical Data from NC318 Phase 1/2 Clinical Trial at the 34th Annual Meeting of SITC
NextCure Presents Preclinical Data on NC318, a Novel Immunomedicine Targeting Siglec-15, at the Society for Immunotherapy of Cancer’s (SITC) 33rd Annual Meeting (PDF)
